Close Menu

NEW YORK – Laboratory Corporation of America said on Tuesday that it will use Thermo Fisher Scientific's Ion Torrent Genexus System and Oncomine Precision Assays for research and development of companion diagnostics as well as for other future oncology and precision medicine applications.

The company said that if the Thermo Fisher system is cleared or approved for diagnostic use, it could also be installed in smaller LabCorp facilities as well as hospitals and at the site of other LabCorp customers to expand access to "efficient, expedient, and cost-effective NGS testing."

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.